A male patient with a 107g prostate underwent an aquablation procedure for symptomatic benign prostatic hyperplasia (bph).Procept biorobotics corporation became aware that during the first treatment pass, the aquabeam handpiece high-velocity waterjet resected the prostatic tissue abnormally deeper than the originally planned resection angles by the treating surgeon; however, the high-velocity waterjet quickly returned to normal.The treating surgeon proceeded with aquablation therapy and completed a total of 2.5 passes.After removing the aquabeam handpiece and while looking in the patient with the resectoscope, the treating surgeon observed that a ureteral orifice was perforated.A stent was placed to treat the perforation.
|
The aquabeam robotic system is a reusable device; therefore it is currently in the possession of the user facility.The investigation of this event consisted of a review of the event treatment logs, device history record (dhr) and procept's risk documentation.A review of the device history record (dhr) ab2000-b/serial number (b)(6) was conducted, which confirmed that there were no non-conformances, failures, discrepancies, or missed steps during the manufacturing process that could be related to the reported event.The review indicated that the system met all design and manufacturing specifications when released for distribution.The aquabeam robotic system instructions for use (ifu), ifu0101-00, rev.E, was reviewed.Although the aquabeam robotic system labeling does not specifically mention damage to ureteral orifices, procept's risk management documentation includes damage to ureteral orifices as a clinical effect of the aquablation procedure.A review of the event logs revealed very little high velocity waterjet activity beyond the bladder neck inside of the bladder.Damage to the ureteral orifices would not have been predicted unless they were in an atypical location adjacent to the bladder neck.The aquabeam robotic system is a reusable device; therefore, it is still currently in possession of the user facility.Although the aquabeam robotic system labeling does not specifically mention damage to ureteral orifices, procept's risk management documentation includes damage to ureteral orifices as a clinical effect of the aquablation procedure.Based on the event details and a review of the event treatment logs, dhr, and procept's risk documentation, the event is considered not to be device-related.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
|